The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Drug-induced Osteoporosis: Mechanisms and Clinical Implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Risk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Self-citationEndocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Pöstlberger, S., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Bjelic-Radisic, V., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806285 · Cited by 1,025
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review
Brown, T. T., & Qaqish, R. B. (2006) · AIDS · doi:10.1097/qad.0b013e32801022eb · Cited by 925
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Self-citationLrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Yadav, V. K., Ryu, J.-H., Suda, N., Tanaka, K. F., Gingrich, J. A., Schütz, G., Glorieux, F. H., Chiang, C. Y., Zajac, J. D., Insogna, K. L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.059 · Cited by 834
Mechanisms of Anabolic Therapies for Osteoporosis
Canalis, E., Giustina, A., & Bilezikian, J. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067395 · Cited by 668
Self-citationVan Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
Loke, Y. K., Singh, S., & Furberg, C. D. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.080486 · Cited by 551
Rosiglitazone-Associated Fractures in Type 2 Diabetes
Kahn, S. E., Zinman, B., Lachin, J. M., Haffner, S. M., Herman, W. H., Holman, R. R., Kravitz, B. G., Yu, D., Heise, M. A., Aftring, R. P., et al. (2008) · Diabetes Care · doi:10.2337/dc07-2270 · Cited by 537
PPAR-γ regulates osteoclastogenesis in mice
Wan, Y., Chong, L.-W., & Evans, R. M. (2007) · Nature Medicine · doi:10.1038/nm1672 · Cited by 517
Triant, V. A., Brown, T. T., Lee, H., & Grinspoon, S. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0828 · Cited by 490
Ellis, G. K., Bone, H. G., Chlebowski, R., Paul, D., Spadafora, S., Smith, J., Fan, M., & Jun, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3832 · Cited by 483
Risk for fracture in women with low serum levels of thyroid-stimulating hormone
Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00009 · Cited by 467
Coleman, R. E., Banks, L. M., Girgis, S. I., Kilburn, L. S., Vrdoljak, E., Fox, J., Cawthorn, S. J., Patel, A., Snowdon, C. F., Hall, E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70003-7 · Cited by 426
Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer
Greenspan, S. L., Coates, P., Sereika, S. M., Nelson, J. B., Trump, D. L., & Resnick, N. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0183 · Cited by 411
Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
Richards, J. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.2.188 · Cited by 386
Dahlman, T. C. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90378-v · Cited by 379
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0021-7 · Cited by 372
Smith, M. R., Lee, W. C., Brandman, J., Wang, Q., Botteman, M., & Pashos, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6908 · Cited by 366
Angeli, A., Guglielmi, G., Dovio, A., Capelli, G., de Feo, D., Giannini, S., Giorgino, R., Moro, L., & Giustina, A. (2006) · Bone · doi:10.1016/j.bone.2006.02.005 · Cited by 365
Self-citationMonréal, M., Lafoz, E., Olivé, A., et al. (1994) · PubMed · Cited by 352
Monreal, M., Lafoz, E., Olive, A., del Rio, L., & Vedia, C. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642376 · Cited by 299
Leidig-Bruckner, G., Hosch, S., Dodidou, P., Ritschel, D., Conradt, C., Klose, C., Otto, G., Lange, R., Theilmann, L., Zimmerman, R., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03641-2 · Cited by 267
Smith, M. R., Fallon, M. A., Lee, H., & Finkelstein, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032058 · Cited by 248
Smith, M. R., Goode, M., Zietman, A. L., McGovern, F. J., Lee, H., & Finkelstein, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.174 · Cited by 188
Rabaglio, M., Sun, Z., Price, K. N., Castiglione-Gertsch, M., Hawle, H., Thürlimann, B., Mouridsen, H., Campone, M., Forbes, J. F., Paridaens, R. J., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp033 · Cited by 186
Effects of warfarin on bone. Studies on the vitamin K-dependent protein of rat bone.
Price, P. A., & Williamson, M. K. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42959-6 · Cited by 182
Brufsky, A., Bundred, N., Coleman, R., Lambert-Falls, R., Mena, R., Hadji, P., Jin, L., Schenk, N., Ericson, S., & Perez, E. A. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0206 · Cited by 175
Anti-epileptic medication and bone health
Petty, S. J., O’Brien, T. J., & Wark, J. D. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0185-z · Cited by 174
Douketis, J. D., Ginsberg, J. S., Burrows, R. F., Duku, E., Webber, C. E., & Brill-Edwards, P. A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650255 · Cited by 169
(1993) · Europe PMC (PubMed Central) · Cited by 167
Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro
Tuukkanen, J., & Väänänen, H. K. (1986) · Calcified Tissue International · doi:10.1007/bf02556841 · Cited by 164
van Diepen, S., Majumdar, S. R., Bakal, J. A., McAlister, F. A., & Ezekowitz, J. A. (2008) · Circulation · doi:10.1161/circulationaha.108.784009 · Cited by 162
Mondy, K. E., Powderly, W. G., Claxton, S., Yarasheski, K. E., Royal, M., Stoneman, J. S., Hoffmann, M. E., & Tebas, P. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000145352.04440.1e · Cited by 161
Warfarin Use and Risk for Osteoporosis in Elderly Women
Jamal, S. A., Browner, W. S., Bauer, D. C., & Cummings, S. R. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-10-199805150-00006 · Cited by 153
Recovery of bone density in women who stop using medroxyprogesterone acetate
Cundy, T., Cornish, J., Evans, M. C., Roberts, H., & Reid, I. R. (1994) · BMJ · doi:10.1136/bmj.308.6923.247 · Cited by 152
Douketis, J. D., Ginsberg, J. S., Burrows, R. F., et al. (1996) · PubMed · Cited by 149
Lee, H., McGovern, K., Finkelstein, J. S., & Smith, M. R. (2005) · Cancer · doi:10.1002/cncr.21381 · Cited by 148
The effects of heparin and low molecular weight heparins on bone
Rajgopal, R., Bear, M., Butcher, M. K., & Shaughnessy, S. G. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.025 · Cited by 135
Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption
Movsowitz, C., Epstein, S., Ismail, F., Fallon, M. D., & Thomas, S. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040314 · Cited by 135
Amin, S., LaValley, M. P., Simms, R. W., & Felson, D. T. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1512 · Cited by 127
Approach to the Patient with Transplantation-Related Bone Loss
Ebeling, P. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0205 · Cited by 127
Confavreux, C. B., Fontana, A., Guastalla, J. P., Munoz, F., Brun, J., & Delmas, P. D. (2007) · Bone · doi:10.1016/j.bone.2007.06.004 · Cited by 127
Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Biondi, B., Iorio, S., Giustina, A., Amato, G., & Carella, C. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041126 · Cited by 126
Self-citationIncrease in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole
Roux, C., Briot, K., Gossec, L., Kolta, S., Blenk, T., Felsenberg, D., Reid, D. M., Eastell, R., & Glüer, C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9188-4 · Cited by 123
Rejnmark, L., Vestergaard, P., Heickendorff, L., Andreasen, F., & Mosekilde, L. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051003 · Cited by 121
Mazziotti, G., Porcelli, T., Patelli, I., Vescovi, P. P., & Giustina, A. (2010) · Bone · doi:10.1016/j.bone.2009.10.031 · Cited by 113
Self-citationHuang, J. S., Meixner, L., Fernández, S. L., & McCutchan, J. A. (2008) · AIDS · doi:10.1097/qad.0b013e32831c8adc · Cited by 100
Greenspan, S. L., Brufsky, A., Lembersky, B. C., Bhattacharya, R. K., Vujevich, K. T., Perera, S., Sereika, S. M., & Vogel, V. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2967 · Cited by 94
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone
Mancini, T., Mazziotti, G., Doga, M., Carpinteri, R., Simetovic, N., Vescovi, P. P., & Giustina, A. (2009) · Bone · doi:10.1016/j.bone.2009.06.006 · Cited by 89
Self-citationOrcel, P., Denne, M. A., & de Vernejoul, M. C. (1991) · Endocrinology · doi:10.1210/endo-128-3-1638 · Cited by 88
Smith, M. R., Malkowicz, S. B., Chu, F. M., Forrest, J. B., SIEBER, P. R., Barnette, K. G., Rodriquez, D., & Steiner, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5517 · Cited by 84
Thyroid Hormones: Beneficial or Deleterious for Bone?
Lakatos, P. L. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-0027-8 · Cited by 78
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9124-7 · Cited by 77
Loop Diuretic Use and Fracture in Postmenopausal Women: Findings From the Women's Health Initiative
Carbone, L. D., Johnson, K., Bush, A. J., Robbins, J., Larson, J. C., Thomas, A. M., & LaCroix, A. Z. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.526 · Cited by 74
Approach to the Prostate Cancer Patient with Bone Disease
Greenspan, S. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1402 · Cited by 69
Levothyroxine treatment and occurrence of fracture of the hip
Sheppard, M. C., Holder, R., & Franklyn, J. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.338 · Cited by 56
US and UK guidelines for glucocorticoid-induced osteoporosis: Similarities and differences
Compston, J. E. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0085-1 · Cited by 55
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2008) · Contraception · doi:10.1016/j.contraception.2008.07.014 · Cited by 51
Single‐Point Assessment of Warfarin Use and Risk of Osteoporosis in Elderly Men
Woo, C., Chang, L. L., Ewing, S. K., Bauer, D. C., & for the Osteoporotic Fractures in Men Study Group (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01786.x · Cited by 51
Cancer Treatment–Related Bone Loss: A Review and Synthesis of the Literature
Khan, M. N., & Khan, A. A. (2008) · Current Oncology · doi:10.3747/co.2008.174 · Cited by 50
Abrahamsen, B., & Brixen, K. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0711-2 · Cited by 42
Planas, J., Trilla, E., Raventos, C. X., Cecchini, L., Orsola, A., Salvador, C., Placer, J., Encabo, G., & Moróte, J. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08622.x · Cited by 39
Osteoporosis and Thyrotropin-Suppressive Therapy: Reduced Effectiveness of Alendronate
Panico, A., Lupoli, G., Fonderico, F., Marciello, F., Martinelli, A., Assante, R., & Lupoli, G. (2009) · Thyroid · doi:10.1089/thy.2008.0428 · Cited by 34
Incidence and risk factors for low trauma fractures in men with prostate cancer
Ahlborg, H. G., Nguyen, N. D., Eisman, J. A., & Nguyen, T. V. (2008) · Bone · doi:10.1016/j.bone.2008.05.003 · Cited by 31
Prevention and treatment of glucocorticoid-induced osteoporosis
Curtis, J. R., & Saag, K. G. (2007) · Current Osteoporosis Reports · doi:10.1007/bf02938618 · Cited by 29
Kearns, A. E., Northfelt, D., Dueck, A. C., Atherton, P. J., Dakhil, S. R., Rowland, K. M., Fuloria, J., Flynn, P. J., Dentchev, T., & Loprinzi, C. L. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0655-x · Cited by 25
Kulak, C. A. M., Borba, V. Z. C., Kulak, J., & Shane, E. J. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000400023 · Cited by 23
Prevention and treatment of glucocorticoid-induced osteoporosis.
Doga, M., Mazziotti, G., Bonadonna, S., Patelli, I., Bilezikian, J. P., CANALIS, E. M., & Giustina, A. (2008) · PubMed · Cited by 17
Self-citation
Cited by
Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Guidelines for the diagnosis, prevention and management of osteoporosis
Rossini, M., Adami, S., Bertoldo, F., Diacinti, D., Gatti, D., Giannini, S., Giusti, A., Malavolta, N., Minisola, S., Osella, G., et al. (2016) · Reumatismo · doi:10.4081/reumatismo.2016.870 · Cited by 272
Glucocorticoids and the regulation of growth hormone secretion
Mazziotti, G., & Giustina, A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.5 · Cited by 206
Self-citationDiabetes in Cushing syndrome: basic and clinical aspects
Mazziotti, G., Gazzaruso, C., & Giustina, A. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.09.001 · Cited by 193
Self-citationMazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Self-citation
Metadata
- Authors
- Mazziotti, G., Canalis, E., & Giustina, A.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 123
- Issue
- 10
- Pages
- 877-884
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1986533422
- Cited by
- 262
- References
- 77
- FWCI
- 23.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.